Alicja Matusiak
Psychiatric/Mental Health · Columbus, OHNPI 1174757678
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 567 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 567 payments — averaging $19.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$2K
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Alkermes, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Neurocrine Biosciences, Inc.$808
- plus $2K from 13 others
What the payments were for
- Food & beverage$10,50497%
- Education$3793%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 95 | $2,267 |
| AbbVie | 162 | $1,801 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 50 | $1,504 |
| Alkermes, Inc. | 55 | $1,295 |
| Otsuka America Pharmaceutical, Inc. | 54 | $1,090 |
| Neurocrine Biosciences, Inc. | 37 | $808 |
| Axsome Therapeutics, Inc. | 40 | $686 |
| Sunovion Pharmaceuticals Inc. | 18 | $334 |
| Lundbeck LLC | 18 | $281 |
| Tris Pharma Inc | 9 | $207 |
| Johnson & Johnson | 5 | $168 |
| Vanda Pharmaceuticals Inc. | 8 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $138 |
| Noven Therapeutics, LLC | 3 | $48 |
| Noven Pharmaceuticals, Inc. | 2 | $38 |
| Almatica Pharma LLC | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$916
- CAPLYTA$755
- ARISTADA$500
- VRAYLAR$480
- AUSTEDO$246
- Austedo XR$230
- REXULTI$227
- ARISTADA INITIO$125
- INGREZZA$125
- INVEGA SUSTENNA$123
- UZEDY$121
- Auvelity$116
- Dyanavel XR$102
- Quillichew ER$102
- Quillivant$102
How this compares
$10,882 in reported general payments places this provider in the 95th percentile of 1,808 psychiatric/mental health providers in Ohio.
Other psychiatric/mental health in Columbus
- Holly SchweitzerColumbus$78K
- David HuffmanColumbus$50K
- Tarsicio GacheruColumbus$18K
- Summer LawsonColumbus$11K
- Gregory BlankenshipColumbus$10K
- Jennifer WilsonColumbus$10K
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.